Paratek Pharmaceuticals, Inc. (PRTK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.9100+0.1300 (+2.72%)
At close: 4:00PM EDT
4.8500 -0.06 (-1.22%)
After hours: 04:15PM EDT
After hours: 04:15PM EDT
| Previous close | 4.7800 |
| Open | 4.8100 |
| Bid | 4.8500 x 1000 |
| Ask | 5.0800 x 1200 |
| Day's range | 4.7000 - 4.9900 |
| 52-week range | 4.5100 - 11.2400 |
| Volume | 326,932 |
| Avg. volume | 398,507 |
| Market cap | 239.582M |
| Beta (5Y monthly) | 1.55 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.1770 |
| Earnings date | 03 Nov 2021 - 08 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 31 Oct 2014 |
| 1y target est | 21.75 |
- Simply Wall St.
When Will Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Turn A Profit?
Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ) is possibly approaching a major achievement in its business, so we would...
- Zacks
Paratek's (PRTK) Nuzyra Gets FDA's Orphan Drug Tag for NTM
The FDA bestows an Orphan Drug designation to Paratek's (PRTK) marketed drug Nuzyra for the treatment of infections caused by Nontuberculous Mycobacteria.
- Simply Wall St.
What Percentage Of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Shares Do Insiders Own?
The big shareholder groups in Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ) have power over the company. Large...
© 2021 Verizon Media. All rights reserved.
